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THE IMPACT OF RACE AND LANGUAGE CONCORDANCE BETWEEN  
 
PATIENTS AND NAVIGATORS ON TIME TO DIAGNOSTIC RESOLUTION OF  
 
BREAST AND CERVICAL CANCER SCREENING ABNORMALITIES 
 
MARJORY CHARLOT 
 
ABSTRACT 
 
Background: Patient navigators have been shown to reduce cancer disparities 
among racial/ethnic minorities by improving timely diagnosis and treatment of 
cancer. We sought to determine if race/ethnicity and language concordance of 
patients and their navigator improved time to diagnostic resolution of breast and 
cervical cancer screening abnormalities.   
Methods: Demographic data on patients and navigators from the Boston Patient 
Navigation Research Program were used to assess concordance by race, 
ethnicity, and language. Kaplan-Meier survival curves and Cox proportional 
hazards regression models examined the association of race/ethnicity and 
language concordance on time to definitive diagnosis of cancer screening 
abnormalities. All analyses were performed separately for breast and cervical 
groups.   
Results: There were 1257 patients and 23 navigators in this study. In the breast 
group (n=655), 44% of patient-navigator pairs were concordant by race/ethnicity 
and 75% were language concordant. In the cervical group (n=602), 70% of 
patient-navigator pairs were race/ethnicity concordant and 87% were language 
concordant. There was no association with race/ethnicity concordance and time 
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to diagnostic resolution for the breast group, aHR 1.19 (95% CI: 0.97, 1.46) or 
cervical group, aHR 1.23 (95% CI: 0.99, 1.53). However, in the stratified analysis, 
race/ethnicity concordance was associated with timelier resolution for minority 
women with breast and cervical cancer screening abnormalities but not for 
Whites. For cervical cancer screening abnormalities resolving in less than 90 
days, language concordance was also associated with timelier resolution, aHR of 
1.46 (95% CI: 1.18, 1.80) but there was no association in the breast group. In the 
subgroup analysis of Spanish concordance there was also an association of 
timelier resolution for those with cervical cancer screening abnormalities 
resolving in less than 90 days. 
Conclusion: Patient-navigator race/ethnicity concordance is associated with 
timelier diagnostic resolution of breast and cervical cancer screening 
abnormalities among minority women.  Language concordance is also 
associated with timelier resolution in participants with cervical cancer screening 
abnormalities despite the availability and use of interpreters. Given poorer cancer 
outcomes among minority women, the use of patient navigators that are diverse 
by race/ethnicity and multilingual may help address barriers to care and improve 
health outcomes among low-income minorities.  
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 1 
Introduction 
Incidence and mortality rates of breast and cervical cancer in the United 
States vary by race and ethnicity. There is a higher incidence of breast cancer 
among White women compared to all races yet higher mortality rates among 
Black women.1  However, Hispanic and Asian women have the lowest breast 
cancer incidence and mortality rates.1 Cervical cancer is not as prevalent as 
breast cancer among American women and mortality rates have dramatically 
declined between 1955 and 1970 with the introduction of the Papanicolau (Pap) 
test.2 Despite overall lower incidence and mortality rates in cervical cancer, there 
is a disproportionate burden of disease among Black and Hispanic women 
compared to Whites.3 
Reasons for the disproportionate mortality rates among Black and 
Hispanic women with breast and cervical cancer are multifactorial and may be 
due to different tumor characteristics such as the aggressive estrogen, 
progesterone, and Her-2 neu negative receptor type of breast cancer more 
common in Black women4, or later stage of disease at diagnosis for both breast 
and cervical cancer, which may be influenced by social factors such as lower 
socioeconomic status, less access to care, or cultural health beliefs.5  Prior 
studies examining these socio-cultural factors have found that regardless of race 
or ethnicity, access to cancer screening is increased with access to health 
insurance5 and mammography and Pap test rates are similar among White, 
Black, and Hispanic women.6  However, despite similar screening rates, 
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racial/ethnic minorities still seem to have a delay in both the follow up of 
abnormal screening tests and in the initiation of cancer treatment.6,7  
Patient navigation programs have been shown in several studies to 
reduce delays in cancer care8. Patient navigators work as patient advocates and 
have a wide range of prior professional training including training as lay 
community health workers, licensed social workers, case managers and nurses. 
They are usually imbedded within the clinical care practice and conduct their 
work with access to clinical providers as well as scheduling and billing personnel. 
Navigators work to reduce barriers to care by helping patients acquire health 
insurance, gain access to care at Federally Qualified Health Centers or safety net 
hospitals, address logistical barriers such as transportation and child care, 
educate patients to improve knowledge, facilitate communication between 
patients and their providers, and encourage patients to follow through with their 
care.6,7,9 Several studies also show that timelier resolution of abnormal screening 
mammography among minorities and low income women can be achieved when 
navigators coordinate care, provide health education and counseling to address 
barriers to care.10-12  
 Along with the important role of patient navigators, understanding and 
improving patient-provider interactions have also been shown in the literature to 
play an important role in improving health outcomes. Patient-provider 
relationships are paramount to communicating and obtaining health information, 
delivery and acceptance of health services, as well as patient trust and 
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satisfaction.13-26 Race, ethnicity, and language are factors that are known to 
influence the patient-provider relationship and may play an important role in 
health disparities. These influences not only pertain to a patient’s perception of 
the type and quality of care received but have also been found to relate to the 
stereotypes held by health care providers who care for a diverse group of 
patients.13,22,25 Prior studies report that minority patients experience lower quality 
interpersonal care with providers13,27, less utilization of health services15,19,20,26, 
and less satisfaction with their care14,18,27, all of which could contribute to poorer 
cancer outcomes.  
Race, ethnicity and language concordance between patients and 
providers may possibly mitigate health disparities by facilitating improved patient-
provider relationships and better health outcomes. Research into the impact of 
patient-physician race and language concordance have shown mixed findings 
depending on the health outcome measured and have been primarily studied in 
retrospective observational or cross sectional studies.15-21,23-25,27 Up to now, there 
has been a gap in the literature on studies that examine the role of concordance 
by race or language in the health setting with health care staff other than 
physicians.  Little is known about the role of patient-navigator race and language 
concordance on follow up of cancer screening abnormalities. The goal of this 
study was to examine the impact of race/ethnicity and language concordance 
between patients and navigators on time to diagnostic resolution of breast and 
cervical cancer screening abnormalities. 
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Methods 
Data Source and Study Population  
This is a secondary data analysis of the Boston Patient Navigation 
Research Program (PNRP), a quasi-experimental patient navigation intervention 
for approximately 3,000 women over the age of 18 with either breast or cervical 
cancer screening abnormalities diagnosed at one of six Boston neighborhood 
Community Health Centers (CHCs) from January 1, 2007 to December 31, 2008. 
The primary study was a non randomized group design with a new standard of 
care such that all patients at the intervention sites received navigation. Three 
CHCs were assigned to navigate patients with abnormal breast cancer screening 
results and the other three CHCs navigated patients with cervical cancer 
screening abnormalities.  Each site served as a control for the non-navigated 
cancer screening abnormality. Depending on the size of the health center, each 
was provided resources for a 0.5 – 1 full time equivalent navigator position.  The 
Boston University Institutional Review Board approved the study.8,28  
The patient navigation intervention consisted of female navigators hired as 
employees of the community health centers and were imbedded within the 
clinical care team interacting with clinical providers and staff in their day to day 
work. They were trained by the PNRP research staff to identify and document 
barriers to care, develop individual plans to address barriers, and follow women 
to diagnostic resolution of their cancer screening abnormality or to the end of 
treatment if diagnosed with cancer.  Their initial interaction with patients occurred 
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via telephone after the patient was informed of an abnormal cancer screening 
result by their clinician.  Patient navigators had access to interpreter services if 
they could not communicate with the patient. Subsequent patient interactions 
were face to face, via telephone and/or mail. Patient navigators also attended 
bimonthly trainings on topics such as effective communication, cultural 
competency, and patient empowerment. Each health center identified a clinical 
supervisor, who was also trained to provide navigation in addition to provide 
supervision, and who was available during the navigator’s absences or during 
transition periods in staffing.  All interactions were documented in the electronic 
medical record. Data on follow up of abnormal screening findings were also 
collected through manual chart abstraction.8  
 
Inclusion/Exclusion Criteria 
By design all women with abnormal breast or cervical cancer screening 
abnormalities at the 6 CHCs were included in the primary study.  For this 
secondary analysis, only women on the navigation arm of the study with one 
navigator were included. Participants with support from more than one navigator 
were excluded from this analysis given the primary exposure of interest was 
race/ethnicity and language concordance between each patient-navigator pair.   
Participants with more than one navigator had the possibility of interacting with 
navigators of various racial/ethnic backgrounds and/or language abilities 
potentially complicating measurement of the exposure. Women on the control 
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arm of the primary study were also excluded from this analysis since they did not 
have a navigator. 
 
Measurement of Outcome:  
The primary outcome of interest was time to diagnostic resolution defined 
as the time from the initial screening abnormality to definitive imaging study, 
repeat Pap test, or biopsy after an abnormal screening test. All women included 
in the study were followed until the time of diagnostic resolution or up to 365 days 
from the date of the screening abnormality. Participants whose abnormalities 
were not resolved by 365 days were censored at 365 days and those who died 
were censored at date of death. The clinicians caring for the patient determined 
the time point for when the abnormality was considered resolved. Given that 
patients with a radiographic BIRADS 3 abnormality are recommended to have a 
repeat mammogram every 180 days for two years, we followed subjects to 
confirm that the first repeat imaging was completed.  Participants with a 
radiographic BIRADS 3 abnormality that resolved before 180 days were counted 
as having their screening abnormality resolved at day 0.5 for the purpose of 
statistical analyses while all others had 180 days subtracted from the diagnostic 
evaluation time in order to compare all the screening abnormalities in a similar 
time frame.8  
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Measurement of Exposure  
The two main exposures of interest were race/ethnicity concordance and 
language concordance.  We defined race/ethnicity concordance as a 
dichotomous variable based on patient and navigator race. Race and ethnicity 
data were identified through health center registration records for all patients and 
were self-identified for navigators. Prior validation with a different sample of 
patients comparing registration data with self-identified race information showed 
high correlation and agreement measured by a Kappa score with values ranging 
from 81-91% for all racial/ethnic groups.29  We imputed race/ethnicity for 8% of 
subjects using in hierarchical order provider’s notes in the medical record, 
primary language, country of origin, or the patient’s surname.8 Race and ethnicity 
were combined into four mutually exclusive categories of Asian, Hispanic, non-
Hispanic Black, and non-Hispanic White. Patients and navigators of the same 
race or ethnicity were classified as race concordant and pairs of different race or 
ethnicity were classified as race discordant. Language concordance was also a 
dichotomous variable based on patient and navigator language.  For missing 
patient language, approximately 6% was imputed as other than English if there 
was documentation of another language in the medical record, need for 
interpreter, or result letter sent to the patient in a language other than English.8 
All navigators were English speaking and 5 navigators also spoke either Spanish 
Vietnamese, or Albanian. Patients and navigators that were able to communicate 
in the same language were classified as language concordant and pairs that 
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could not communicate in a common language were classified as language 
discordant. 
 
Covariate Assessment  
Patient age, race/ethnicity, language, socioeconomic status measured as 
percent of zip code under federal poverty level, insurance status (public, private, 
and no insurance including those with free care), and type of screening 
abnormality were obtained from the administrative billing and electronic medical 
records. These covariates were assessed given this was a secondary analysis of 
a non-randomized study design and because of their potential to confound or 
modify the effect of time to diagnostic resolution of the screening abnormality 
with respect to race and language concordance. 
 
Statistical Analyses  
An a priori decision was made to conduct analyses separately for breast 
and cervical screening groups as done in the primary study given there were 
different demographic characteristics of the participants, particularly by age and 
race and because of the different recommendations for management of 
screening abnormalities and varying severity of abnormalities. Descriptive 
bivariate associations of demographic and clinical characteristics were examined 
to compare race concordant to race discordant patient-navigator pairs as well as 
language concordant to language discordant pairs. In addition, bivariate 
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associations of demographic and clinical characteristics were examined to 
compare those with screening abnormalities that ever resolved to those that 
never resolved. To assess the bivariate associations, chi-square tests and 
Fisher’s exact tests were employed for categorical variables and Student’s t tests 
were used for continuous variables.  
For the primary unadjusted analyses, Kaplan-Meier survival curves were 
generated to assess the effect of race and language concordance on time to 
diagnostic resolution of breast and cervical cancer screening abnormalities. The 
Logrank test was used for significance testing. Univariate and multivariate Cox 
proportional hazards regression models were used to assess the association 
between race and language concordance with time to diagnostic resolution.  
Proportional hazards assumptions were tested graphically using the survival 
curves for difference in the effect over time, and because of violation of the 
proportionality assumptions multiplicative interaction terms between concordance 
and time were employed. Since differences in the effect over time occurred at 
around 90 days for most curves, hazard ratios were calculated for 0-89 days and 
90-365 days where needed for significant time interactions.  
Multivariate analyses were adjusted for age, race/ethnicity, language, 
insurance status, type of screening abnormality and clustering by patient 
navigator. Adjustment for clustering by patient navigator was employed to control 
for the influence of the individual patient navigator.  To assess the varying effect 
of race concordance by the different race/ethnicity groups, a stratified analysis 
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was performed comparing White concordant to White discordant, Black 
concordant to Black discordant and Hispanic concordant to Hispanic discordant 
patient-navigator pairs. Asian patient-navigator pairs were excluded in stratified 
analyses for cervical screening abnormalities due to the small numbers in the 
study sample. We also performed a subgroup analysis of language concordance 
for Spanish speakers only given all of our navigators spoke English and therefore 
there were no English discordant pairs and the numbers were too small for 
languages other than English or Spanish. Stratified analyses were adjusted only 
for age, insurance status and clustering by navigator given the subgroup analysis 
included smaller numbers and these covariates were important with respect to 
the study outcome of time to diagnostic resolution. All analyses were performed 
with SAS statistical software (SAS Institute, Cary, NC). 
 
Results 
Patient and Navigator Characteristics 
There were a total of 1257 women with either breast (n= 655) or cervical 
(n=602) cancer screening abnormalities and 23 navigators. Over two thirds of 
women with breast cancer screening abnormalities were between the ages of 40 
and 59 years, 56% were non-White, 63% spoke English, and 50% had public 
insurance. The most common breast cancer screening abnormality was BIRADS 
category 0 (66%) which refers to a finding that needs additional imaging 
evaluation.30 (Table 1.1) 
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Women with cervical cancer screening abnormalities were younger than 
the breast group with over 80% under the age of 39 years. They were mostly 
Black and Hispanic (comprising 80% of cervical cancer screening group) and one 
third of these women spoke only Spanish while nearly 60% spoke English.  Most 
were either uninsured (41%) or had public insurance (37%). Over 96% of the 
screening abnormalities were low-grade cervical lesions.  (Table 1.2) 
There were 23 female patient navigators and they were primarily White 
(57%). All patient navigators were able to communicate in English and 21% were 
also able to communicate in either Spanish or Vietnamese.  Navigators with data 
available on age were young and mostly between the ages of 24 and 29 years. 
(Table 2.1) 
 
Race/Ethnicity Concordance: Breast Cancer Screening Abnormalities 
Forty four percent of the patient-navigator pairs were concordant by race 
or ethnicity. Race/ethnicity concordant groups compared to discordant groups 
were predominately White (75% vs. 20%). There were significant differences 
between the concordant and discordant groups in age, race/ethnicity, language, 
insurance status, socioeconomic status, and screening abnormality (Table 1.1). 
The rate of diagnostic resolution of breast cancer screening abnormalities at 90 
days was over 85% for both the race/ethnicity concordant and discordant groups 
and at 365 days over 90% of screening abnormalities were resolved for 
race/ethnicity concordant and discordant groups. (Table 3.1)   
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In the unadjusted analysis of time to diagnostic resolution by race/ethnicity 
concordance status represented by Kaplan-Meier curves (Figure 1.1), there was 
no statistically significant difference between the race/ethnicity concordant and 
discordant groups (p=0.26). Univariate and multivariate Cox proportional hazards 
models for time to diagnostic resolution of breast cancer screening abnormalities 
(Tables 4.1 and 5.1) also did not show a statistically significant difference 
between race concordant and discordant patient-navigator pairs. However, the 
multivariate analysis stratified by patient race/ethnicity and adjusted for age, 
insurance status, and clustering by navigator, showed that minority women in 
race concordant groups had timelier resolution of their screening abnormalities. 
Hazard ratio greater >1 in the Cox models represented timelier resolution. Black 
concordant patient-navigator pairs compared to Black discordant pairs were 
nearly three times as likely to have timelier resolution of screening abnormalities 
that resolved after 90 days (aHR 2.62, 95% CI: 1.56 to 4.41); however, at less 
than 90 days Black concordant patient-navigator pairs had less timely resolution 
of their screening abnormalities. Hispanic and Asian concordant patient-navigator 
pairs had a 30% or more likelihood of timelier resolution of breast cancer 
screening abnormalities resolving before 90 days. There was no association with 
time to diagnostic resolution of breast cancer screening abnormalities and White 
race concordance status. (Table 6.1) 
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Race/Ethnicity Concordance: Cervical Cancer Screening Abnormalities 
Among the cervical cancer screening group, 70% of patient-navigator 
pairs were concordant by race or ethnicity.  Race/ethnicity concordant groups 
compared to discordant groups were mostly Black (40% vs. 19%) and Hispanic 
(55% vs. 26%). There were significant differences between the concordant and 
discordant groups in race/ethnicity, language, insurance status, and 
socioeconomic status (Table 1.2). The rate of diagnostic resolution of cervical 
cancer screening abnormalities at 90 days was 65% for race/ethnicity concordant 
group and 62% for discordant groups. At 365 days 94% of race concordant 
groups and 87% of race discordant groups ever achieved diagnostic resolution of 
cancer screening abnormalities and this finding was statistically significant (Table 
3.1).   
The Kaplan-Meier curves in Figure 1.2 represents the unadjusted analysis 
of time to diagnostic resolution of cervical cancer screening abnormalities by 
race/ethnicity concordance status and show no statistically significant difference 
between the race concordant and discordant groups (p=0.07). The univariate and 
multivariate cox proportional hazard models for time to diagnostic resolution by 
race/ethnicity concordance status were also not statistically significant but there 
appeared to be a trend toward race/ethnicity concordant groups having timelier 
resolution compared to race/ethnicity discordant groups. In the stratified 
multivariate analysis, again minority women in race/ethnicity concordant groups 
had timelier resolution of their screening abnormalities. Hispanic patients with a 
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Hispanic navigator had an 80% more likelihood of having timelier resolution of 
their cancer screening abnormality (aHR 1.82 95%CI: 1.39 to 2.39) and this 
association did not vary with time.  Black patients with a Black navigator were 
50% more likely to have timelier resolution of cervical cancer screening 
abnormality that resolved after 90 days (aHR 1.50, 95%CI: 1.35 to 1.67).  
However, there was a negative association between White race concordance 
status and time to diagnostic resolution (aHR 0.60 95%CI 0.48 to 0.76). (Table 6)  
 
Language Concordance: Breast Cancer Screening Abnormalities 
Over 75% of patient navigator pairs in the breast cancer screening group 
were language concordant.  Since all navigators spoke English, there were no 
English discordant patient-navigator pairs. The largest non-English speaking 
groups were Spanish and Vietnamese speakers and the percentage of Spanish 
speakers in the language concordant and discordant groups was fairly similar 
(12% and 20%) while the percentage of Vietnamese speakers were unbalanced 
comprising only 4% of the language concordant group and 75% of language 
discordant groups.  At 90 days close to 90% of language concordant patient-
navigator pairs had diagnostic resolution of cancer screening abnormalities 
compared to only 80% in the language discordant groups and this finding was 
statistically significant (Table 3.1).  
The unadjusted analysis of time to diagnostic resolution by language 
concordance status represented by the Kaplan-Meier curve in figure 2.1, shows a 
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suggestion of the language concordant group having timelier resolution than 
language discordant groups and this finding had borderline significance (p=0.05). 
Table 4.1 also shows that in the univariate Cox proportional hazards models of 
time to diagnostic resolution by language concordance status that language 
concordant groups are 30% more likely to have timelier resolution than language 
discordant groups (HR 1.30 95% CI:1.06 to 1.58). However, in the subgroup 
analysis of Spanish speaking study participants, there was no association 
between time to diagnostic resolution of breast cancer screening abnormalities 
and Spanish concordance status after adjusting for age, insurance status and 
clustering by navigator (Table 6.1). The subgroup analysis was limited to Spanish 
speakers given there were no English discordant groups for comparison to the 
English discordant group and the number of participants with languages other 
than English or Spanish were too small for comparison.  
 
Language Concordance: Cervical Cancer Screening Abnormalities 
Eighty seven percent of patient-navigator pairs in the cervical group were 
language concordant. One third of the women in the language concordant and 
discordant groups were Spanish speakers and racial/ethnic distribution was 
similar between the groups and comprised mostly of Black and Hispanic women. 
At 90 days, over 60% of cervical cancer screening abnormalities had diagnostic 
resolution in both the language concordant and discordant groups, and at 365 
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days over 90% of cancer screening abnormalities were resolved in both groups 
(Table 3.2).  
In the unadjusted analysis, the Kaplan-Meier curve in Figure 2.2 shows no 
difference between language concordant and discordant groups in time to 
diagnostic resolution of cervical cancer screening abnormalities. In the 
multivariate proportional hazard models (Table 5.1), language concordant groups 
had timelier resolution of cancer screening abnormalities that resolved in less 
than 90 days (HR=1.46, 95% CI: 1.18, 1.80) after adjusting for race/ethnicity, 
age, language, insurance, socioeconomic status, screening abnormality and 
clustering by navigator. In addition, after adjusting for age, insurance status, and 
clustering by navigator, the subgroup analysis of Spanish speakers showed that 
Spanish concordant pairs were 43% more likely to have timelier resolution of 
cervical cancer screening abnormalities resolving in less than 90 days (aHR 
1.43, 95% CI: 1.10, 1.84) with a marginal positive association for concordant 
groups with resolution occurring at 90 days or more. 
 
Discussion 
Delays in follow up of cancer screening abnormalities have been found to 
be associated with poor health outcomes.10 This study sought to determine the 
impact of patient and navigator race/ethnicity and language concordance on time 
to diagnostic resolution of breast and cervical cancer screening abnormalities. 
Many but not all of our findings indicated that minority women with race/ethnicity 
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concordant navigators had timelier resolution of breast and cervical cancer 
screening abnormalities compared to race/ethnicity discordant groups. In 
contrast, there was either no association or no benefit of race concordance for 
White participants in this study.  
The benefit of race/ethnicity concordance among minority women varied 
with time with exception of Hispanic women in the cervical cancer screening 
group that benefited from having a Hispanic navigator for abnormalities that 
resolved before and after 90 days. Differences in the association of race/ethnicity 
concordance with time to diagnostic resolution of cancer screening abnormalities 
among minority women may be explained by differences in culture and level of 
acculturation among and within different racial/ethnic groups26. Given the 
younger population of those with cervical cancer screening abnormalities, they 
may be newly arrived immigrants and represent a less acculturated population. 
The negative association between race concordance and time to diagnostic 
resolution of breast cancer screening abnormalities resolving in less than 90 
days among Black concordant patient-navigator group was an exception among 
minority study participants. Our sample of the Black race concordant group with 
breast cancer screening abnormalities included only 5 patient-navigator pairs and 
therefore it is difficult to draw any conclusions on this finding on such a small 
sample. However, the sample of race concordant Black women in the cervical 
group was larger and showed a benefit of race/ethnicity concordance for 
abnormalities that resolved in 90 or more days and no association with 
 18 
abnormalities that resolved in less than 90 days. This suggests that the benefit of 
race concordance for Black women may occur later and a race concordant 
navigator may mitigate the factors associated with delayed resolution of cancer 
screening abnormalities. Prior studies on patient-provider race concordance and 
health outcomes have had mixed findings with a few studies showing a modest 
association particularly for minorities.19,20,24,26 A literature review of 27 studies (all 
observational) found inconclusive evidence for the association of patient-provider 
race concordance and health outcomes and argued that these findings could be 
a result of small sample size, patient self report of health outcomes, and 
evaluating race concordance with physician providers only.22 The design of our 
study differs from the existing literature in that we prospectively assessed the 
impact of patient and navigator race/ethnicity concordance using an objectively 
defined study outcome.  
The finding of no association between race concordance and time to 
diagnostic resolution among White women with breast cancer screening 
abnormalities may be related to high diagnostic resolution rates for both race 
concordant and discordant groups thereby making it difficult to assess a 
difference between the groups. Also, White study participants may face fewer 
cultural barriers in a health system where providers and staff are predominately 
White.26 However, reasons for the negative association between White race 
concordance status and resolution of cervical cancer screening abnormalities are 
unclear but may be due to cultural discordance within the White race concordant 
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group, for example, White Albanian patients paired with White American 
navigators, or unmeasured factors such as competing priorities resulting in these 
differences. It is also possible that minority navigators may be better at identifying 
and addressing barriers to care among White women and other minority women 
seeking care at urban community health centers.  
Our findings on language concordance demonstrated timelier resolution of 
cervical cancer screening abnormalities for language concordant groups. The 
subgroup analysis of Spanish speaking patients also showed the benefit of 
language concordance among those with cervical cancer screening 
abnormalities.  Even though most participants in this study were English 
speaking about one third were non-English speakers suggesting that having a 
navigator that can communicate in the same language was beneficial.  Our 
findings also suggest that despite interpreter use among the language discordant 
group that having a navigator that can communicate in the same language is 
ideal. Our finding is consistent with prior studies showing a benefit of language 
concordance among non-English speaking populations but these studies focused 
on patient-provider interactions.23,26 We were able to show that the use of 
linguistically concordant navigators can also improve outcomes particularly 
among those with language barriers. 
There was no association between language concordance and timely 
diagnostic resolution of breast cancer screening abnormalities. This lack of 
association particularly among the breast cancer screening group may again be 
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related to the high rate of diagnostic resolution. There may have also been fewer 
language barriers among this group given they were mostly English speakers 
and older women who may have been in this country long enough to understand 
English.  
While this study is able to elucidate the impact of race and language 
concordance among 4 distinct racial/ethnic cohort, there are limitations. First, this 
was a secondary data analysis and race and language concordant and 
discordant groups were not balanced for either the breast or cervical cancer 
screening groups.  Second, given the study design, our subgroup analysis of 
language concordance was limited because the study population was primarily 
English speakers and all navigators spoke English therefore limiting our 
understanding of the effect of language concordance for non-English speakers 
other than Spanish speakers.  
 
Conclusion 
Our data suggest that patient-navigator race/ethnicity and language 
concordance may be beneficial for minority women particularly for Hispanic 
women with cervical cancer screening abnormalities.  Even with the use and 
availability of interpreters, Spanish language concordant patient-navigator pairs 
have timelier resolution of cervical cancer screening abnormalities. Given poorer 
cancer outcomes among minority women, the use of patient navigators that are 
diverse by race/ethnicity and multilingual may help address barriers to care and 
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improve health outcomes for a low-income minority population. Future research 
on patient-navigator relationships may further contribute to our understanding of 
the dynamics involved in improving delays in diagnostic resolution of cancer 
screening abnormalities. 
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Table 1.1 Baseline characteristics of participants with breast cancer screening abnormalities by race and 
language concordance status. 
 Total 
N=651 
 
Col % 
Race 
Concordant 
N=286 
Col % 
Race 
Discordant 
N=365 
Col % 
P-value Total 
N=655 
Language 
Concordant 
N=494 
Col % 
Language 
Discordant 
N=161 
Col % 
P-value 
Age 
18-29 
30-39 
40-49 
50-59 
60-69 
70-79 
80+ 
 
 
31 (5) 
74 (11) 
269(41) 
168(26) 
72 (11) 
33 (5) 
4 (<1) 
 
22 (8) 
39 (14) 
111 (39) 
60 (21) 
33 (12) 
17 (6) 
4 (1) 
 
9 (3) 
35 (10) 
158 (43) 
108 (30) 
39 (11) 
16 (4) 
0 (0) 
0.001  
32 (5) 
74 (11) 
272 (42) 
168 (26) 
72 (11) 
33 (5) 
4 (<1) 
 
29 (6) 
62 (13) 
213 (43) 
114 (23) 
49 (10) 
23 (5) 
4 (<1) 
 
3 (2) 
12 (7) 
59 (37) 
54 (34) 
23 (14) 
10 (6) 
0 (0) 
0.01 
Race/ 
Ethnicity 
White 
Black 
Asian 
Hispanic 
 
 
 
289(44) 
99 (15) 
127(20) 
136(21) 
 
 
215 (75) 
5 (2) 
29 (10) 
37 (13) 
 
 
74 (20) 
94 (26) 
98 (27) 
99 (27) 
<.0001  
 
291 (44) 
100 (15) 
127 (19) 
137 (21) 
 
 
242 (49) 
93 (19) 
52 (11) 
107(22) 
 
 
49 (30) 
7 (4) 
75 (47) 
30 (19) 
<.0001 
Language 
English 
Spanish 
Vietnamese 
Other 
 
 
412(63) 
88 (14) 
96 (15) 
55 (8) 
 
197 (69) 
24 (8) 
22 (8) 
43 (15) 
 
215 (59) 
64 (18) 
74 (20) 
12 (3) 
<.0001  
414 (63) 
90 (14) 
96 (15) 
55 (8) 
 
414 (84) 
58 (12) 
22 (4) 
0 (0) 
 
0 (0) 
32 (20) 
74 (46) 
55 (34) 
<.0001 
Insurance 
Public 
Private 
Uninsured 
 
 
327(50) 
220(34) 
104(16) 
 
113 (40) 
128 (45) 
45 (16) 
 
214 (59) 
92 (25) 
59 (16) 
<.0001  
330 (50) 
221 (34) 
104 (16) 
 
236 (48) 
198 (40) 
60 (12) 
 
94 (58) 
23 (14) 
44 (27) 
<.0001 
% Zip Code 
 Below Federal 
Poverty Level  
Mean ± 
 SD 
 
 
 
 
14.74 ± 
6.9 
 
 
 
13.59 ±  
6.34 
 
 
 
15.64 ±  
7.19 
0.0001 
 
 
 
 
14.74 ± 
6.9 
 
 
 
15.06 ±  
6.92 
 
 
 
 
13.77 ± 
 6.77 
 
0.04 
SCREENING 
ABNORMALITY  
Clinical 
BIRADS 0 
BIRADS 3 
BIRADS 4/5 
 
 
 
161(25) 
431(66) 
51 (8) 
8 (1) 
 
 
91 (32) 
172 (60) 
23 (8) 
0 (0) 
 
 
70 (19) 
259 (71) 
28 (8) 
8 (2) 
0.0002  
 
164 (25) 
432 (66) 
51 (8) 
8 (1) 
 
 
 
133 (27) 
318 (64) 
37 (8) 
6 (1) 
 
 
 
31 (19) 
114 (71) 
14 (9) 
2 (1) 
 
0.28 
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Table 1.2 Baseline characteristics of participants with cervical cancer screening abnormalities by race and 
language concordance status. 
 Total 
N=598 
 
Col % 
Race 
Concordant 
N=420 
Col % 
Race 
Discordant 
N=178 
Col % 
P-value Total 
N=602 
Language 
Concordant 
N=526 
Col % 
Language 
Discordant 
N= 76 
Col % 
P-value 
Age 
18-29 
30-39 
40-49 
50-59 
60-69 
70-79 
 
 
357 (60) 
143 (24) 
73 (12) 
19 (3) 
3 (<1) 
3 (<1) 
 
248 (59) 
108 (26) 
46 (11) 
14 (3) 
1 (<1) 
3 (<1) 
 
109 (61) 
35 (20) 
27 (15) 
5 (3) 
2 (1) 
0 (0) 
0.21  
361 (60) 
143 (24) 
73 (12) 
19 (3) 
3 (0.5) 
3 (0.5) 
 
328 (62) 
122 (23) 
57 (11) 
13 (3) 
3 (0.6) 
3 (0.6) 
 
33 (43) 
21 (28) 
16 (21) 
6 (8) 
0 (0) 
0 (0) 
0.004 
Race/ 
Ethnicity 
White 
Black 
Asian 
Hispanic 
 
 
 
115 (19) 
201 (34) 
7 (1) 
275 (46) 
 
 
23 (5) 
168 (40) 
0 (0) 
229 (55) 
 
 
92 (52) 
33 (18) 
7 (4) 
46 (26) 
<.0001  
 
115 (19) 
202 (34) 
7 (1) 
278 (46) 
 
 
98 (19) 
172 (32) 
6 (1) 
250 (48) 
 
 
17 (22) 
30 (40) 
1 (1) 
28 (37) 
0.34 
Language 
English 
Spanish 
Vietnamese 
Other 
 
 
355 (59) 
195 (33) 
1 (<1) 
47 (8) 
 
220 (52) 
168 (40) 
0 (0) 
32 (8) 
 
135 (76) 
27 (15) 
1 <1) 
15 (8) 
<.0001  
357 (59) 
197 (33) 
1 (<1) 
47 (8) 
 
357 (68) 
168 (32) 
0 (0) 
1 (<1) 
 
0 (0) 
29 (38) 
1 (1) 
46 (61) 
<.0001 
Insurance 
Public 
Private 
Uninsured 
 
 
220 (37) 
133 (22) 
245 (41) 
 
144 (34) 
80 (19) 
196 (47) 
 
76 (43) 
53 (30) 
49 (28) 
<.0001  
222 (37) 
135 (22) 
245 (41) 
 
193 (37) 
125 (24) 
208 (40) 
 
29 (38.16) 
10 (13.16) 
37 (48.68) 
0.09 
% Zip Code 
 Below Federal 
Poverty Level  
Mean ± 
 SD 
 
 
 
 
14.45 ± 
5.46 
 
 
 
14.97 ±  
5.33 
 
 
 
13.23 ±  
5.6 
0.0003  
 
 
14.48 ± 
5.46 
 
 
 
14.68 ±  
5.37 
 
 
 
13.11 ±  
5.92 
0.02 
Cervical  
LGL 
HGL 
 
 
575 (96) 
23 (4) 
 
403 (96) 
17 (4) 
 
172 (97) 
6 (3) 
0.69  
578 (96) 
24 (4) 
 
508 (97) 
18 (3) 
 
70 (92) 
6 (8) 
0.06 
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Table 2.1. Navigator Characteristics 
Navigator 
Characteristics 
Total N=23 
Col % 
Age 
24-29 
30-39 
40-49 
50-59 
Missing 
 
 
6 (26) 
1 (4) 
3 (13) 
1 (4) 
12 (52) 
 
Race/Ethnicity 
White 
Black 
Hispanic 
Asian 
Missing 
 
 
13 (57) 
4 (17) 
3 (13) 
1 (4) 
2 (9) 
 
Language  
English only 
Spanish 
Vietnamese 
Albanian 
 
 
18 (78) 
3 (13) 
1 (4) 
1 (4) 
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Table 3.1 Bivariate analysis of race and language concordance status by percent of 
breast cancer screening abnormalities resolved at 90 and 365 days. 
 % 
Resolved 
at 90 days 
P-value % 
Resolved 
at 365 days 
P-value 
Race concordant 
Yes 
No 
 
Language 
Concordant 
Yes 
No 
 
85% 
86% 
 
 
87% 
80% 
0.87 
 
 
 
0.03 
 
93% 
96% 
 
 
95% 
95% 
0.11 
 
 
 
0.82 
 
 
Table 3.2 Bivariate analysis of race and language concordance status by percent of 
cervical cancer screening abnormalities resolved at 90 and 365 days. 
 % 
Resolved 
at 90 days 
P-value % 
Resolved 
at 365 
days 
P-value 
Race concordant 
Yes 
No 
 
Language 
Concordant 
Yes 
No 
 
65% 
62% 
 
 
64% 
63% 
0.42 
 
 
 
0.83 
 
94% 
87% 
 
 
91% 
94% 
0.01 
 
 
 
0.50 
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Table 4.1. Univariate cox proportional hazard model predicting time to diagnostic 
resolution 
 Breast Cervical 
 <90 days 90-365 days <90 days 90-365 days 
Race concordant v. 
discordant 
1.16 
(0.98, 1.38) 
0.62 
(0.37, 1.05) 
1.18 
(0.98, 1.43) 
1.18 
(0.98, 1.43) 
     
Language 
concordant v. 
discordant 
1.30 
(1.06, 1.58) 
0.67 
(0.41, 1.12) 
1.12 
(0.83, 1.51) 
 
0.82 
(0.53, 1.27) 
 
Table 5.1. Multivariate cox proportional hazard model predicting time to diagnostic 
resolution 
 Breast Cervical 
 <90 days 90-365 days <90 days 90-365 days 
*Race concordant v. 
discordant 
1.19 
(0.97, 1.46) 
1.19 
(0.97, 1.46) 
1.23 
(0.99, 1.53) 
1.23 
(0.99, 1.53) 
     
*Language 
concordant v. 
discordant 
1.13 
(0.80, 1.59) 
1.04 
(0.70, 1.55) 
1.46 
(1.18, 1.80) 
 
1.16 
(0.65, 2.07) 
*Adjusted for race/ethnicity age, language, insurance, SES, screening abnormality, and 
clustering by navigator 
 
Table 6.1. Stratified Multivariate cox proportional hazard model predicting time to 
diagnostic resolution 
*Race Concordance Breast 
 
Cervical 
 <90 days 90-365 days <90 days 90-365 days 
White concordant v. 
discordant 
0.98 
(0.83, 1.16) 
0.98 
(0.83, 1.16) 
0.60 
(0.48, 0.76) 
0.60 
(0.48, 0.76) 
Black concordant v. 
discordant 
0.86 
(0.75, 0.99) 
2.62 
(1.56, 4.41) 
0.91 
(0.47, 1.79) 
1.50 
(1.35, 1.67) 
Hispanic concordant 
v. discordant 
1.37 
(1.06, 1.77) 
1.49 
(0.83, 2.67) 
1.82 
(1.39, 2.39) 
1.82 
(1.39, 2.39) 
Asian concordant v. 
discordant 
1.29 
(1.07, 1.55) 
0.98 
(0.83, 1.16) 
--- --- 
     
*Language 
Concordance 
    
Spanish concordant 
v. discordant 
1.10 
(0.69, 1.75) 
1.10 
(0.69, 1.75) 
1.43 
(1.10, 1.84) 
1.63 
(1.00, 2.66) 
* Adjusted for age, insurance status, and clustering by navigator 
--- Asian population not included in stratified analysis for cervical screening group due to 
small numbers 
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Figure 1.1. Time to resolution by race concordance status among patients with breast 
cancer screening abnormalities 
 
 
 
Figure 1.2 Time to resolution by race concordance status among patients with cervical 
cancer screening abnormalities 
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Figure 2.1 Time to resolution by language concordance status among patients with 
breast cancer screening abnormalities 
 
 
 
Figure 2.2. Time to resolution by language concordance status among patients with 
cervical cancer screening abnormalities 
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